title: Response to Comment on: Harrison et al. β-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 2012;35:1406-1412.
authors.forename: Lindsay B
authors.initials: LB
authors.lastname: Harrison
authors.forename: Philip
authors.initials: P
authors.lastname: Raskin
authors.forename: Ildiko
authors.initials: I
authors.lastname: Lingvay
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D007328:Insulin / Q000008:administration & dosage*; D050417:Insulin-Secreting Cells / Q000502:physiology*; D008297:Male; D008687:Metformin / Q000008:administration & dosage*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin